.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Doctor Solomon's is stocked at 546 licensed dispensaries across Illinois, New Jersey, and 9 other states, 116 of them in Illinois, with the deepest coverage in Chicago, Springfield, Quincy, East Dubuque, and Joliet. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
Doctor Solomon's category mix in August 2026 tilts toward Topical at 41.53% share and Tincture & Sublingual at 33.71%, while Concentrates holds 24.76% share; within this, Topical is down 24.32% YoY but up 5.06% MoM, and Tincture & Sublingual is down 10.86% YoY but up 17.66% MoM. Concentrates bucks the annual trend with 7.49% YoY growth but slid 5.95% MoM, aligning with the brand’s overall sales decline of 13.65% YoY and a price reset of 7.32% YoY; the brand sits at rank 11 in Concentrates in Maryland, indicating mid-pack placement. The implication is a portfolio in transition: near-term lift in Topical and Tincture & Sublingual offsets some monthly softness in Concentrates, but the double-digit annual declines in two largest lines signal that mix alone won’t reverse the 24-month drop of 24.09% without deeper pricing or product architecture moves.
The mix shifts imply a trade-off between volume capture via price and category emphasis: the 7.32% YoY average price reduction likely supported the 17.66% MoM rebound in Tincture & Sublingual and the 5.06% MoM uptick in Topical, but the 5.95% MoM dip in Concentrates at a 24.76% share constrained aggregate recovery. Holding rank 11 in Concentrates in Maryland while Concentrates grows 7.49% YoY suggests the brand’s competitive position is steadier in that niche than in its larger Topical and Tincture & Sublingual bases, so leaning into improving Concentrates velocity while stabilizing price architecture in the larger categories is the clearest path to offsetting the 13.65% YoY brand sales decline.
Competitive Landscape
Doctor Solomon's ranks #11 in MD Concentrates in August 2026, improving 5 positions year over year from #16 and advancing 4 spots since May 2026 from #15 to #11, while its historical peak was #9 in October 2024, placing current performance 2 ranks below that high. In contrast, District Cannabis held #1 with a 42.9% year-over-year sales gain and Grassroots rose from #3 to #2 with 25.0% growth, indicating that top-tier momentum outpaced mid-tier rank recovery; this pattern implies Doctor Solomon's ascent is real but capped by faster comp expansion at the top, signaling a path that likely stabilizes around the low-teens unless share-accretive moves close the 2-rank gap to its October 2024 peak.
Notable Products
Creamsicle Sunset RSO Syringe (1g) posted the steepest decline at -33.39% and slipped to rank 8, while OG Kush RSO Syringe (1g) surged +55.63% to rank 5. CBD/THC 1:1 Restore Transdermal Lotion (200mg CBD, 200mg THC, 1.8oz) advanced +29.79% to rank 2 as the 100mg/100mg 1oz variant rose +13.94% at rank 1. With three Concentrates SKUs in the top ten, performance skewed toward a bifurcation where fast-rising RSO offsets a double-digit drop, implying the brand is consolidating share around momentum SKUs rather than broadening the SKU base.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
